-PEG below 1-Trailing PE of 14x-Excellent growth in water purification and sterilization-Embedded option for bird flu and/or mad cow-Strong management and acquisition potentialI would be very surprised if this stock were not at least 50% higher 12 months from now. Conservative DCF model gets it as nearly a double.
Current PEG here does not mean much, because earnings will be decreased in July(?) when the deal with Olympus ends. Also growth will probably be slowed somewhat with the loss of this partner. For the same reason, you can't use trailing PE to determine value in a company that is losing a major partner in a couple months.